Midgard Science
wuxiXDC

wuxiXDC

Singapore, Singapore wuxixdc.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

WuXi XDC is a CRDMO focused on discovery, development, and cGMP manufacturing for ADCs and other bioconjugates. It serves global biopharmaceutical partners from sites in Wuxi, Shanghai, Changzhou, and Singapore.

wuxiXDC is a CRDMO in Singapore. It lists 8 services, including Bioconjugation Discovery, Bioconjugation Process Development and Analytical Development. It names GMP on its listing.

Services

  • Bioconjugation Discovery

    Generates, engineers, evaluates, and optimizes ADCs and other bioconjugates to identify lead candidates.

  • Bioconjugation Process Development

    Provides process development, scale-up, and tech-transfer support for ADCs, bioconjugates, and diagnostic or imaging reagents.

  • Analytical Development

    Provides analytical development services for bioconjugates.

  • Formulation and DP Development

    Designs liquid, frozen, or lyophilized dosage forms for bioconjugates and related advanced molecular complexes.

  • GMP mAb Intermediate and Conjugation Manufacturing

    Manufactures mAb intermediates and ADC drug substance under GMP conditions.

    CDMO: development & manufacturing

  • GMP Formulation, Fill and Lyophilization

    Provides GMP drug product formulation, filling, and lyophilization services for bioconjugates.

    CDMO: development & manufacturing

  • Payload and Linker R&D and Manufacturing

    Develops and manufactures payload-linker components for bioconjugates.

  • Ready-Made Payloads & Linkers

    Offers ready-made payloads and linkers for bioconjugate development and manufacturing.

How to order from wuxiXDC

They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • ADCs
  • Process development
  • Lyophilization
  • Analytical development
  • Antibodies
  • Bispecifics
3 more
  • Oligonucleotides
  • QC release testing
  • Stability testing
Scale and capacity
  • 5 L to 500 L single-use reactor systems
  • 50 L to 2,000 L per batch
  • Up to 2 x 2,000 L bioreactors
  • 3 million vials per year
  • 5 million doses of bioconjugate drug products per year
Therapeutic areas
  • Cancer
  • Autoimmune diseases

Instruments and platforms

  • Lyophilizer 1×5 m2
  • Lyophilizer 1×20 m2

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Oligonucleotide
  • Recombinant protein

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRDMO
Team
Over 2000 skilled employees
Based in
Singapore, Singapore
Sites
  • Wuxi, China
  • Shanghai, China
  • Changzhou, China
Serves
Global

Similar labs